Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-236-5 | CAS number: 455-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Genotoxicity in vitro:
Ames test
One Ames test with reliability 2 (Hazleton, 1986) was available and selected as key study. The summary of this study was the following:
In
a reverse gene mutation assay in bacteria (Hazleton, 1986), strains TA
98, TA 100, TA 1535, TA 1537 and TA 1538 of S. typhimurium were exposed
to paratrifluoromethylaniline at concentrations of 0.05,
0.1, 0.5, 1 or
2 µl/plate in the presence and absence of mammalian metabolic activation.
Paratrifluoromethylaniline was tested up to cytotoxic concentrations.
The positive controls induced the appropriate responses in the
corresponding strains.
In this study, the test item presented mutagenic activity with and without S9 -mix in Salmonella typhimurium TA100 and TA1535. A weak positive response in TA1537 and negative response for TA98 and TA1538.
Therefore,
p-TFMA is considered as mutagenic for Salmonella typhimurium under the
test conditions.
This study is classified as acceptable. This study satisfies the
requirement for Test Guideline OECD 471 for in vitro mutagenicity
(bacterial reverse gene mutation) data.
Another one study (Quillardet, 1993) was with reliabilty 3 was not retained for the assesment, because it was not well described, and it was not an usual genotoxicity test.
In vitro mammalian cell gene mutation test
One HPRT study (Hoechst, 1994) was available and selected as key study because it was with reliability 1. The summary of this study was the following:
The study (Hoechst, 1993) was performed to investigate the potential of p-trifluoromethylaniline to induce gene mutations at the HGPRT locus in V79 cells of the Chinese hamster in vitro.
The assay was performed in two independent experiments, using identical procedures, both with and without rat liver microsomal activation (S9 -mix).
The test substance was tested at the following concentrations: 10, 25, 50, 100 and 250 µg/ml without S9 -mix; 50, 100, 250, 500 and 750 µg/ml with S9 -mix.
The concentration ranges were selected according to the preliminary experiment for toxicity. The concentration of 500 µg/ml with metabolic activation produced a distinct decrease of the plating efficiency in the main experiment.
P-trifluoromethylaniline produced a statistically significant increase in mutant colony number in the absence and the presence of S9 -mix. This effect was reproductible and slightly dose-dependent.
Appropriate reference mutagens were used as positive controls ans showed a distinct increase in induced mutant colonies.
In conclusion, p-trifluoromethylaniline induce gene mutations in the HGPRT-test with V79 Chinese hamster cells, in the presence and in the absence of a metabolic activation system, under the experimental described.
Therefore p-trifluoromethylaniline is considered to be mutagenic in this HGPRT assay.
In vitro mammalian chromosome aberration test
One Chromosome aberration study (Hoechst, 1994) was available and was selected as key study because it was with reliability 1. The summary of this study was the following:
The study (Hoechst, 1994) was performed to investigate the potential of p-trifluoromethylaniline to induced chromosome aberrations in V79 cells of the Chinese hamster in vitro.
The assay was performed in two independent experiments, using identical procedures, both with and without rat liver microsomal activation (S9-mix). For each experiment two cell cultures were used.
The test article was tested at the following concentrations:
Without S9-mix:
18h: 10, 50 and 100 µg/ml
28h: 100 µg/ml
With S9-mix:
18h: 10, 250 and 500 µg/ml
28h: 500 µg/ml
The concentration ranges were selected according to the preliminary experiment for solubility and toxicity. The highest concentration produced a distinct decrease of the mitotic index with metabolic activation.
The test compound induced a statistically significant increase in the number of chromosome aberrations inclusive and exclusive gaps at the fixation intervals 18 and 28 h with metabolic activation. Without S9 -mix, 18 hours after treatment only the aberration rate inclusive gaps was significative enhanced, while at fixation interval 28 hours also an increased number of aberrant cells exclusive gaps was observed.
Appropriate reference mutagens were used as positive controls and showed a distinct increase in chromosome aberrations, thus indicating the sensitivity of the assay.
In conclusion, p-trifluoromethylaniline does induce chromosome mutations (=aberrations) in V79 Chinese hamster cells, in the presence and in the absence of a metabolic activation system, under the experimental conditions described.
Therefore p-trifluoromethylaniline is considered to be mutagenic in this chromosome aberration assay.
Short description of key information:
p-TFMA gave positive results in Ames tests, with and without metabolic activation system.
p-TFMA gave positive results in gene mutation test with V79 Chinese hamster cells, with and without metabolic activation system.
p-TFMA gave positive results in chromosome aberration test with V79 Chinese hamster cells, with and without metabolic activation system.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
P-trifluoromethylaniline showed positive results in Ames test, in mammalian gene mutation test and in chromosome aberration test with mammalian cells, in vitro.
However, these positive results in in-vitro studies are not sufficient to classify p-TFMA as mutagenic. An in-vivo study is needed, but such a test is not required for strictly controlled intermediates.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.